Freeloaders and token theft are undermining AI economics. Companies need to watch out29 September 2026
NASA backs Boeing capsule after earlier mission was classified as a crew-endangering ‘Type A mishap’29 September 2026
Taxpayer-funded pro-Trump ads violate laws against ‘publicity and propaganda,’ legal experts say29 September 2026
The Multi-Billion-Dollar Battle For MetseraBy Press Room5 November 2025 In this week’s edition of InnovationRx, we look at the battle for Metsera, the departure of FDA’s top drug regulator,…
Coverage Of Weight Loss Drugs By Medicaid Plans Continues To LagBy Press Room7 August 2025 California recently passed a budget for 2025-2026 that eliminates Medicaid coverage for GLP-1 agonists for weight loss. Other states are…
Ozempic-Like Drugs May Hold Risks For Surgical Patients, Officials SayBy Press Room30 January 2025 Officials in the U.K. have warned that increasingly popular weight-loss drugs like Ozempic may carry extra risks for people who…
Mounjaro/Zepbound Drastically Cuts Risk Of Type 2 Diabetes, Eli Lilly Report SuggestsBy Press Room20 August 2024 Topline New study results found weight loss and diabetes drugs Zepbound and Mounjaro may significantly cut the risk of diabetes…